Treatment of coronary bifurcation lesions with drug-eluting stents: insights from the first phase of the prospective multicenter german drug-eluting stent registry

Background: Controversy exists about the impact of treating bifurcations on overall outcome of coronary interventions using drug-eluting stents (DES). We sought to investigate 1-year outcome of the treatment of bifurcation lesions using DES in a large “real-world” cohort. Methods and Results: Among...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Abdel-Wahab, Mohamed S. (VerfasserIn) , Hochadel, Matthias (VerfasserIn) , Senges, Jochen (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: August 2012
In: Journal of interventional cardiology
Year: 2012, Jahrgang: 25, Heft: 4, Pages: 344-352
ISSN:1540-8183
DOI:10.1111/j.1540-8183.2011.00718.x
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1111/j.1540-8183.2011.00718.x
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1540-8183.2011.00718.x
Volltext
Verfasserangaben:Mohamed Abdel‐Wahab, M.D., Christoph A. Nienaber, M.D., Ahmad E. Mostafa, M.D., Miroslaw Ferenc, M.D., Sigmund Silber, M.D., Georg Sabin, M.D., Ulrich Tebbe, M.D., Ibrahim Akin, M.D., Matthias Hochadel, Ph.D., Jochen Senges, M.D., Karl-Heinz Kuck, M.D. and Gert Richardt, M.D. on behalf of the German Drug‐Eluting Stent (DES.DE) Registry

MARC

LEADER 00000caa a2200000 c 4500
001 1582645272
003 DE-627
005 20230427193252.0
007 cr uuu---uuuuu
008 181107s2012 xx |||||o 00| ||eng c
024 7 |a 10.1111/j.1540-8183.2011.00718.x  |2 doi 
035 |a (DE-627)1582645272 
035 |a (DE-576)512645272 
035 |a (DE-599)BSZ512645272 
035 |a (OCoLC)1341022470 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Abdel-Wahab, Mohamed S.  |d 1974-  |e VerfasserIn  |0 (DE-588)1172771693  |0 (DE-627)1041409605  |0 (DE-576)160014328  |4 aut 
245 1 0 |a Treatment of coronary bifurcation lesions with drug-eluting stents  |b insights from the first phase of the prospective multicenter german drug-eluting stent registry  |c Mohamed Abdel‐Wahab, M.D., Christoph A. Nienaber, M.D., Ahmad E. Mostafa, M.D., Miroslaw Ferenc, M.D., Sigmund Silber, M.D., Georg Sabin, M.D., Ulrich Tebbe, M.D., Ibrahim Akin, M.D., Matthias Hochadel, Ph.D., Jochen Senges, M.D., Karl-Heinz Kuck, M.D. and Gert Richardt, M.D. on behalf of the German Drug‐Eluting Stent (DES.DE) Registry 
264 1 |c August 2012 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 04.12.2018 
520 |a Background: Controversy exists about the impact of treating bifurcations on overall outcome of coronary interventions using drug-eluting stents (DES). We sought to investigate 1-year outcome of the treatment of bifurcation lesions using DES in a large “real-world” cohort. Methods and Results: Among 5,126 patients enrolled in phase I of the multicenter German Drug-Eluting Stent Registry, 814 (16%) were treated for a bifurcation lesion. Patients with bifurcations were compared to those without bifurcations in terms of baseline characteristics, major adverse cardiac and cerebrovascular events (MACCE) and target vessel revascularization (TVR) at 1 year. Usage of sirolimus-eluting stents (SES) versus paclitaxel-eluting stents (PES) was also evaluated. In total, 1,021 and 5,189 stents were implanted in the bifurcation (1.25 stents/patient) and nonbifurcation (1.2 stents/patient) group, respectively, but 64.5% of bifurcation lesions were treated with a single stent. More complex lesion and procedural characteristics were observed in the bifurcation group. However, there was no difference in 1-year MACCE rates (a composite of death, myocardial infarction, and stroke) between the bifurcation group and nonbifurcation group (8.1% vs. 8.3%, P = 0.85). Rates of TVR (11.2% vs. 10.8%, P = 0.75) and Academic Research Consoritum-defined definite stent thrombosis (0.9% vs. 0.8%, P = 0.67) were also comparable. MACCE and TVR rates remained similar after adjustment for differences in baseline characteristics. MACCE and TVR in SES patients were 7.2% and 12.6% versus 8.7% and 10.2% in PES patients (P = 0.46 and P = 0.30, respectively). Conclusion: In this large multicenter registry, treatment of bifurcation lesions with DES appears effective and safe. The presence of bifurcations did not affect 1-year outcomes after DES implantation. The outcomes for SES and PES were similar. (J Interven Cardiol 2012;25:344-352) 
700 1 |a Hochadel, Matthias  |e VerfasserIn  |0 (DE-588)1128413051  |0 (DE-627)88289871X  |0 (DE-576)485901811  |4 aut 
700 1 |a Senges, Jochen  |d 1942-  |e VerfasserIn  |0 (DE-588)1027133479  |0 (DE-627)728326620  |0 (DE-576)372508685  |4 aut 
773 0 8 |i Enthalten in  |t Journal of interventional cardiology  |d [Hoboken, NJ] : Wiley, 1988  |g 25(2012), 4, Seite 344-352  |h Online-Ressource  |w (DE-627)361350058  |w (DE-600)2103585-4  |w (DE-576)10450935X  |x 1540-8183  |7 nnas  |a Treatment of coronary bifurcation lesions with drug-eluting stents insights from the first phase of the prospective multicenter german drug-eluting stent registry 
773 1 8 |g volume:25  |g year:2012  |g number:4  |g pages:344-352  |g extent:9  |a Treatment of coronary bifurcation lesions with drug-eluting stents insights from the first phase of the prospective multicenter german drug-eluting stent registry 
856 4 0 |u http://dx.doi.org/10.1111/j.1540-8183.2011.00718.x  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1540-8183.2011.00718.x  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20181107 
993 |a Article 
994 |a 2012 
998 |g 1027133479  |a Senges, Jochen  |m 1027133479:Senges, Jochen  |d 50000  |e 50000PS1027133479  |k 0/50000/  |p 10 
998 |g 1128413051  |a Hochadel, Matthias  |m 1128413051:Hochadel, Matthias  |p 9 
999 |a KXP-PPN1582645272  |e 3030549860 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1582645272","id":{"eki":["1582645272"],"doi":["10.1111/j.1540-8183.2011.00718.x"]},"person":[{"family":"Abdel-Wahab","given":"Mohamed S.","roleDisplay":"VerfasserIn","display":"Abdel-Wahab, Mohamed S.","role":"aut"},{"roleDisplay":"VerfasserIn","role":"aut","display":"Hochadel, Matthias","family":"Hochadel","given":"Matthias"},{"family":"Senges","given":"Jochen","roleDisplay":"VerfasserIn","display":"Senges, Jochen","role":"aut"}],"name":{"displayForm":["Mohamed Abdel‐Wahab, M.D., Christoph A. Nienaber, M.D., Ahmad E. Mostafa, M.D., Miroslaw Ferenc, M.D., Sigmund Silber, M.D., Georg Sabin, M.D., Ulrich Tebbe, M.D., Ibrahim Akin, M.D., Matthias Hochadel, Ph.D., Jochen Senges, M.D., Karl-Heinz Kuck, M.D. and Gert Richardt, M.D. on behalf of the German Drug‐Eluting Stent (DES.DE) Registry"]},"note":["Gesehen am 04.12.2018"],"physDesc":[{"extent":"9 S."}],"language":["eng"],"origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"August 2012"}],"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title_sort":"Journal of interventional cardiology","title":"Journal of interventional cardiology","subtitle":"an international forum for global cardiovascular therapies"}],"origin":[{"publisher":"Wiley ; Blackwell Publishing ; Wiley-Blackwell ; Hindawi","dateIssuedKey":"2024","publisherPlace":"[Hoboken, NJ] ; Oxford [u.a.] ; Oxford [u.a.] ; London","dateIssuedDisp":"2024-"}],"disp":"Treatment of coronary bifurcation lesions with drug-eluting stents insights from the first phase of the prospective multicenter german drug-eluting stent registryJournal of interventional cardiology","part":{"text":"25(2012), 4, Seite 344-352","extent":"9","pages":"344-352","volume":"25","year":"2012","issue":"4"},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["1.1988 -"],"note":["Gesehen am 03.03.2025"],"id":{"issn":["1540-8183"],"zdb":["2103585-4"],"doi":["10.1111/(ISSN)1540-8183"],"eki":["361350058"]},"recId":"361350058"}],"title":[{"title_sort":"Treatment of coronary bifurcation lesions with drug-eluting stents","title":"Treatment of coronary bifurcation lesions with drug-eluting stents","subtitle":"insights from the first phase of the prospective multicenter german drug-eluting stent registry"}],"type":{"bibl":"article-journal","media":"Online-Ressource"}} 
SRT |a ABDELWAHABTREATMENTO2012